Figures
Figure 1 Trial profile
Figure 1 legend: *Two infants in the control group were no
longer eligible due to receiving phototherapy for jaundice after
randomization. The primary outcome was the cumulative incidence of
atopic dermatitis at 12 months.
Abbreviations: CW = Consent withdrawn, LTFU = Lost to follow-up
Figure 2 Point prevalence and cumulative incidence of AD at 12
months in the intervention and control groups
Figure 2 legend: The point prevalence of AD was calculated
based on the number of infants in each group who met the UK Working
Party Diagnostic Criteria for atopic dermatitis at 12 months
(intervention: 24/117, control: 52/136), as assessed by the blinded
investigator. The cumulative incidence of AD was calculated based on the
number of infants diagnosed with AD at any point in the first 12 months
(intervention: 24/117, control: 52/136).
Abbreviations: AD = atopic dermatitis
Figure 3 Kaplan-Meier plot of the proportion of in infants in
the intervention and control group
without AD during the first 12 months of life
Figure 3 legend: The intervention group maintained AD-free skin
for a longer period in the first 12 months than the control group
(P = 0.016, log-rank test).
Abbreviations: AD = atopic dermatitis